Skip to main content
Top
Published in: European Radiology 3/2024

02-09-2023 | Bladder Carcinoma | Urogenital

MRI-based automated machine learning model for preoperative identification of variant histology in muscle-invasive bladder carcinoma

Authors: Jingwen Huang, Guanxing Chen, Haiqing Liu, Wei Jiang, Siyao Mai, Lingli Zhang, Hong Zeng, Shaoxu Wu, Calvin Yu-Chian Chen, Zhuo Wu

Published in: European Radiology | Issue 3/2024

Login to get access

Abstract

Objectives

It is essential yet highly challenging to preoperatively diagnose variant histologies such as urothelial carcinoma with squamous differentiation (UC w/SD) from pure UC in patients with muscle-invasive bladder carcinoma (MIBC), as their treatment strategy varies significantly. We developed a non-invasive automated machine learning (AutoML) model to preoperatively differentiate UC w/SD from pure UC in patients with MIBC.

Methods

A total of 119 MIBC patients who underwent baseline bladder MRI were enrolled in this study, including 38 patients with UC w/SD and 81 patients with pure UC. These patients were randomly assigned to a training set or a test set (3:1). An AutoML model was built from the training set, using 13 selected radiomic features from T2-weighted imaging, semantic features (ADC values), and clinical features (tumor length, tumor stage, lymph node metastasis status), and subsequent ten-fold cross-validation was performed. A test set was used to validate the proposed model. The AUC of the ROC curve was then calculated for the model.

Results

This AutoML model enabled robust differentiation of UC w/SD and pure UC in patients with MIBC in both training set (ten-fold cross-validation AUC = 0.955, 95% confidence interval [CI]: 0.944–0.965) and test set (AUC = 0.932, 95% CI: 0.812–1.000).

Conclusion

The presented AutoML model, that incorporates the radiomic, semantic, and clinical features from baseline MRI, could be useful for preoperative differentiation of UC w/SD and pure UC.

Clinical relevance statement

This MRI-based automated machine learning (AutoML) study provides a non-invasive and low-cost preoperative prediction tool to identify the muscle-invasive bladder cancer patients with variant histology, which may serve as a useful tool for clinical decision-making.

Key Points

• It is important to preoperatively diagnose variant histology from urothelial carcinoma in patients with muscle-invasive bladder carcinoma (MIBC), as their treatment strategy varies significantly.
• An automated machine learning (AutoML) model based on baseline bladder MRI can identify the variant histology (squamous differentiation) from urothelial carcinoma preoperatively in patients with MIBC.
• The developed AutoML model is a non-invasive and low-cost preoperative prediction tool, which may be useful for clinical decision-making.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424CrossRefPubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424CrossRefPubMed
2.
go back to reference Funt SA, Rosenberg JE (2017) Systemic, perioperative management of muscle-invasive bladder cancer and future horizons. Nat Rev Clin Oncol 14:221–234CrossRefPubMed Funt SA, Rosenberg JE (2017) Systemic, perioperative management of muscle-invasive bladder cancer and future horizons. Nat Rev Clin Oncol 14:221–234CrossRefPubMed
3.
go back to reference Witjes JA, Bruins HM, Cathomas R et al (2021) European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: summary of the 2020 guidelines. Eur Urol 79:82–104CrossRefPubMed Witjes JA, Bruins HM, Cathomas R et al (2021) European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: summary of the 2020 guidelines. Eur Urol 79:82–104CrossRefPubMed
4.
go back to reference Cathomas R, Lorch A, Bruins HM et al (2022) The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma. Eur Urol 81:95–103CrossRefPubMed Cathomas R, Lorch A, Bruins HM et al (2022) The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma. Eur Urol 81:95–103CrossRefPubMed
5.
go back to reference Dotson A, May A, Davaro F, Raza SJ, Siddiqui S, Hamilton Z (2019) Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy. Int J Clin Oncol 24:706–711CrossRefPubMed Dotson A, May A, Davaro F, Raza SJ, Siddiqui S, Hamilton Z (2019) Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy. Int J Clin Oncol 24:706–711CrossRefPubMed
6.
go back to reference Berg S, D’Andrea D, Vetterlein MW et al (2019) Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: does histologic subtype matter? Cancer 125:1449–1458CrossRefPubMed Berg S, D’Andrea D, Vetterlein MW et al (2019) Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: does histologic subtype matter? Cancer 125:1449–1458CrossRefPubMed
7.
go back to reference Veskimae E, Espinos EL, Bruins HM et al (2019) What is the prognostic and clinical importance of urothelial and nonurothelial histological variants of bladder cancer in predicting oncological outcomes in patients with muscle-invasive and metastatic bladder cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines panel systematic review. Eur Urol Oncol 2:625–642CrossRefPubMed Veskimae E, Espinos EL, Bruins HM et al (2019) What is the prognostic and clinical importance of urothelial and nonurothelial histological variants of bladder cancer in predicting oncological outcomes in patients with muscle-invasive and metastatic bladder cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines panel systematic review. Eur Urol Oncol 2:625–642CrossRefPubMed
8.
go back to reference Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-Part B: Prostate and bladder tumours. Eur Urol 70:106–119CrossRefPubMed Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-Part B: Prostate and bladder tumours. Eur Urol 70:106–119CrossRefPubMed
9.
go back to reference Necchi A, Raggi D, Gallina A et al (2020) Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies. Eur Urol 77:439–446CrossRefPubMed Necchi A, Raggi D, Gallina A et al (2020) Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies. Eur Urol 77:439–446CrossRefPubMed
10.
go back to reference Li G, Yu J, Song H et al (2017) Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival. BMC Cancer 17:530CrossRefPubMedPubMedCentral Li G, Yu J, Song H et al (2017) Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival. BMC Cancer 17:530CrossRefPubMedPubMedCentral
11.
go back to reference Alfred Witjes J, Lebret T, Comperat EM et al (2017) Updated 2016 EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer. Eur Urol 71:462–475CrossRefPubMed Alfred Witjes J, Lebret T, Comperat EM et al (2017) Updated 2016 EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer. Eur Urol 71:462–475CrossRefPubMed
12.
go back to reference Raman JD, Jafri SM (2015) Surgical management of bladder urothelial carcinoma with squamous differentiation. Urol Oncol 33:429–433CrossRefPubMed Raman JD, Jafri SM (2015) Surgical management of bladder urothelial carcinoma with squamous differentiation. Urol Oncol 33:429–433CrossRefPubMed
13.
go back to reference Mantica G, Tappero S, Parodi S et al (2021) Bladder cancer histological variants: which parameters could predict the concordance between transurethral resection of bladder tumor and radical cystectomy specimens? Cent European J Urol 74:355–361PubMedPubMedCentral Mantica G, Tappero S, Parodi S et al (2021) Bladder cancer histological variants: which parameters could predict the concordance between transurethral resection of bladder tumor and radical cystectomy specimens? Cent European J Urol 74:355–361PubMedPubMedCentral
14.
go back to reference Bi WL, Hosny A, Schabath MB et al (2019) Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin 69:127–157CrossRefPubMedPubMedCentral Bi WL, Hosny A, Schabath MB et al (2019) Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin 69:127–157CrossRefPubMedPubMedCentral
15.
go back to reference Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRefPubMed Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRefPubMed
16.
go back to reference Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446CrossRefPubMedPubMedCentral Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446CrossRefPubMedPubMedCentral
17.
go back to reference Wang H, Xu X, Zhang X et al (2020) Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study. Eur Radiol 30:4816–4827CrossRefPubMed Wang H, Xu X, Zhang X et al (2020) Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study. Eur Radiol 30:4816–4827CrossRefPubMed
18.
go back to reference Wang H, Hu D, Yao H et al (2019) Radiomics analysis of multiparametric MRI for the preoperative evaluation of pathological grade in bladder cancer tumors. Eur Radiol 29:6182–6190CrossRefPubMed Wang H, Hu D, Yao H et al (2019) Radiomics analysis of multiparametric MRI for the preoperative evaluation of pathological grade in bladder cancer tumors. Eur Radiol 29:6182–6190CrossRefPubMed
19.
go back to reference Wu S, Zheng J, Li Y et al (2018) Development and validation of an MRI-based radiomics signature for the preoperative prediction of lymph node metastasis in bladder cancer. EBioMedicine 34:76–84CrossRefPubMedPubMedCentral Wu S, Zheng J, Li Y et al (2018) Development and validation of an MRI-based radiomics signature for the preoperative prediction of lymph node metastasis in bladder cancer. EBioMedicine 34:76–84CrossRefPubMedPubMedCentral
20.
go back to reference Cha KH, Hadjiiski LM, Cohan RH et al (2019) Diagnostic accuracy of CT for prediction of bladder cancer treatment response with and without computerized decision support. Acad Radiol 26:1137–1145CrossRefPubMed Cha KH, Hadjiiski LM, Cohan RH et al (2019) Diagnostic accuracy of CT for prediction of bladder cancer treatment response with and without computerized decision support. Acad Radiol 26:1137–1145CrossRefPubMed
21.
go back to reference Lin P, Wen DY, Chen L et al (2020) A radiogenomics signature for predicting the clinical outcome of bladder urothelial carcinoma. Eur Radiol 30:547–557CrossRefPubMed Lin P, Wen DY, Chen L et al (2020) A radiogenomics signature for predicting the clinical outcome of bladder urothelial carcinoma. Eur Radiol 30:547–557CrossRefPubMed
22.
go back to reference Zheng J, Kong J, Wu S et al (2019) Development of a noninvasive tool to preoperatively evaluate the muscular invasiveness of bladder cancer using a radiomics approach. Cancer 125:4388–4398CrossRefPubMed Zheng J, Kong J, Wu S et al (2019) Development of a noninvasive tool to preoperatively evaluate the muscular invasiveness of bladder cancer using a radiomics approach. Cancer 125:4388–4398CrossRefPubMed
23.
go back to reference van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Can Res 77:e104–e107CrossRef van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Can Res 77:e104–e107CrossRef
24.
25.
go back to reference Fan TW, Malhi H, Varghese B et al (2019) Computed tomography-based texture analysis of bladder cancer: differentiating urothelial carcinoma from micropapillary carcinoma. Abdom Radiol (NY) 44:201–208CrossRefPubMed Fan TW, Malhi H, Varghese B et al (2019) Computed tomography-based texture analysis of bladder cancer: differentiating urothelial carcinoma from micropapillary carcinoma. Abdom Radiol (NY) 44:201–208CrossRefPubMed
26.
go back to reference Amin MB, Greene FL, Edge SB et al (2017) The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 67:93–99 Amin MB, Greene FL, Edge SB et al (2017) The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 67:93–99
27.
go back to reference Zhao J, Gao S, Sun W et al (2021) Magnetic resonance imaging and diffusion-weighted imaging-based histogram analyses in predicting glypican 3-positive hepatocellular carcinoma. Eur J Radiol 139:109732CrossRefPubMed Zhao J, Gao S, Sun W et al (2021) Magnetic resonance imaging and diffusion-weighted imaging-based histogram analyses in predicting glypican 3-positive hepatocellular carcinoma. Eur J Radiol 139:109732CrossRefPubMed
28.
go back to reference Ji GW, Zhang YD, Zhang H et al (2019) Biliary tract cancer at CT: a radiomics-based model to predict lymph node metastasis and survival outcomes. Radiology 290:90–98CrossRefPubMed Ji GW, Zhang YD, Zhang H et al (2019) Biliary tract cancer at CT: a radiomics-based model to predict lymph node metastasis and survival outcomes. Radiology 290:90–98CrossRefPubMed
29.
go back to reference Panebianco V, Narumi Y, Altun E et al (2018) Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 74:294–306CrossRefPubMedPubMedCentral Panebianco V, Narumi Y, Altun E et al (2018) Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 74:294–306CrossRefPubMedPubMedCentral
30.
go back to reference Meyer M, Ronald J, Vernuccio F et al (2019) Reproducibility of CT radiomic features within the same patient: influence of radiation dose and CT reconstruction settings. Radiology 293:583–591CrossRefPubMed Meyer M, Ronald J, Vernuccio F et al (2019) Reproducibility of CT radiomic features within the same patient: influence of radiation dose and CT reconstruction settings. Radiology 293:583–591CrossRefPubMed
31.
go back to reference Baessler B, Weiss K, Pinto Dos Santos D (2019) Robustness and reproducibility of radiomics in magnetic resonance imaging: a phantom study. Invest Radiol 54:221–228CrossRefPubMed Baessler B, Weiss K, Pinto Dos Santos D (2019) Robustness and reproducibility of radiomics in magnetic resonance imaging: a phantom study. Invest Radiol 54:221–228CrossRefPubMed
32.
go back to reference Zwanenburg A, Vallieres M, Abdalah MA et al (2020) The Image Biomarker Standardization Initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295:328–338CrossRefPubMed Zwanenburg A, Vallieres M, Abdalah MA et al (2020) The Image Biomarker Standardization Initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295:328–338CrossRefPubMed
Metadata
Title
MRI-based automated machine learning model for preoperative identification of variant histology in muscle-invasive bladder carcinoma
Authors
Jingwen Huang
Guanxing Chen
Haiqing Liu
Wei Jiang
Siyao Mai
Lingli Zhang
Hong Zeng
Shaoxu Wu
Calvin Yu-Chian Chen
Zhuo Wu
Publication date
02-09-2023
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 3/2024
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-023-10137-w

Other articles of this Issue 3/2024

European Radiology 3/2024 Go to the issue